Published in Mol Cell Biol on December 01, 2001
Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors. Cancer Cell (2010) 1.88
Molecular alterations in primary prostate cancer after androgen ablation therapy. Clin Cancer Res (2005) 1.88
Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer (2004) 1.73
Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma. Oncogene (2010) 1.39
Interleukin-6 regulates androgen synthesis in prostate cancer cells. Clin Cancer Res (2009) 1.32
Molecular mechanisms of castration-resistant prostate cancer progression. Future Oncol (2009) 1.26
The neuroendocrine-derived peptide parathyroid hormone-related protein promotes prostate cancer cell growth by stabilizing the androgen receptor. Cancer Res (2009) 1.22
Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway. Am J Pathol (2003) 1.07
Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor. Clin Exp Metastasis (2004) 0.98
Oncogenic activation of androgen receptor. Urol Oncol (2008) 0.97
Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patients. Am J Cancer Res (2011) 0.95
The Siah2-HIF-FoxA2 axis in prostate cancer – new markers and therapeutic opportunities. Oncotarget (2010) 0.91
Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer. Am J Pathol (2006) 0.90
Autophagy pathway is required for IL-6 induced neuroendocrine differentiation and chemoresistance of prostate cancer LNCaP cells. PLoS One (2014) 0.89
The spatio-temporal dynamics of PKA activity profile during mitosis and its correlation to chromosome segregation. Cell Cycle (2014) 0.88
Proinflammatory cytokine interleukin-6 in prostate carcinogenesis. Am J Clin Exp Urol (2014) 0.87
Mitogen Activated Protein kinase signal transduction pathways in the prostate. Cell Commun Signal (2004) 0.87
RhoGDIα suppresses growth and survival of prostate cancer cells. Prostate (2011) 0.86
β-Adrenergic Receptor Signaling in Prostate Cancer. Front Oncol (2015) 0.86
EGF prevents the neuroendocrine differentiation of LNCaP cells induced by serum deprivation: the modulator role of PI3K/Akt. Neoplasia (2007) 0.84
Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. Mol Biol Cell (2006) 0.84
Loss of Prkar1a leads to Bcl-2 family protein induction and cachexia in mice. Cell Death Differ (2014) 0.84
Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation. Mol Cancer Ther (2014) 0.84
Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure. Front Oncol (2015) 0.82
Mitogen and stress activated kinases act co-operatively with CREB during the induction of human cytomegalovirus immediate-early gene expression from latency. PLoS Pathog (2014) 0.82
pp32 reduction induces differentiation of TSU-Pr1 cells. Am J Pathol (2004) 0.82
Protein kinase A-mediated phosphorylation of RhoA on serine 188 triggers the rapid induction of a neuroendocrine-like phenotype in prostate cancer epithelial cells. Cell Signal (2012) 0.82
Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells. Br J Cancer (2009) 0.80
JFC1 is transcriptionally activated by nuclear factor-kappaB and up-regulated by tumour necrosis factor alpha in prostate carcinoma cells. Biochem J (2002) 0.80
The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells. Mol Cancer (2014) 0.79
REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling. Oncotarget (2016) 0.78
[Relevance of the neuroendocrine differentiation in prostatic carcinoma]. Pathologe (2005) 0.78
The molecular basis for ethnic variation and histological subtype differences in prostate cancer. Sci China Life Sci (2013) 0.77
GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells. Oncotarget (2016) 0.77
Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle. Open Access J Urol (2010) 0.77
Soluble interleukin-6 receptor to interleukin-6 (sIL‑6R/IL-6) ratio in serum as a predictor of high Gleason sum at radical prostatectomy. Oncol Lett (2011) 0.77
Up-Regulated Expression of LAMP2 and Autophagy Activity during Neuroendocrine Differentiation of Prostate Cancer LNCaP Cells. PLoS One (2016) 0.76
TRIIODOTHYRONINE ATTENUATES PROSTATE CANCER PROGRESSION MEDIATED BY β-ADRENERGIC STIMULATION. Mol Med (2016) 0.75
Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4. Oncotarget (2017) 0.75
Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell (1995) 10.16
Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell (1994) 9.73
Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature (1998) 9.30
A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science (1993) 4.65
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res (1994) 4.32
cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell (1997) 3.93
Interleukin-6 and its receptor: a paradigm for cytokines. Science (1992) 3.51
Interleukin 6 and its receptor: ten years later. Int Rev Immunol (1998) 2.96
Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr Biol (2000) 2.70
A 42-kD tyrosine kinase substrate linked to chromaffin cell secretion exhibits an associated MAP kinase activity and is highly related to a 42-kD mitogen-stimulated protein in fibroblasts. J Cell Biol (1990) 2.41
Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter. Mol Cell Biol (1989) 2.20
Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature (1998) 2.08
Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway . Prostate (2000) 2.03
Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J Urol (1999) 2.00
Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res (1997) 1.95
Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells. Hum Pathol (1995) 1.73
Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate (1999) 1.71
Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc Natl Acad Sci U S A (1998) 1.70
Interleukin-6: a candidate mediator of human prostate cancer morbidity. Urology (1995) 1.62
Interleukin-6: structure-function relationships. Protein Sci (1997) 1.59
Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP. Proc Natl Acad Sci U S A (1994) 1.44
Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo. J Urol (1999) 1.43
STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells . Prostate (2000) 1.40
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cancer Res (1999) 1.37
STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP. Prostate (2000) 1.19
Effect of phosphorylation on activities of Rap1A to interact with Raf-1 and to suppress Ras-dependent Raf-1 activation. J Biol Chem (1999) 1.18
Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6. Int J Cancer (1996) 1.13
Transdifferentiation of cultured human prostate cancer cells to a neuroendocrine cell phenotype in a hormone-depleted medium. Urol Oncol (2011) 1.09
Interleukin 6 receptor mRNA in prostate carcinomas and benign prostate hyperplasia. J Urol (1994) 1.06
The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor. J Biol Chem (1998) 1.03
c-Raf-mediated inhibition of epidermal growth factor-stimulated cell migration. J Biol Chem (1999) 1.03
Parathyroid hormone-related protein: a potential autocrine growth regulator in human prostate cancer cell lines. Urology (1994) 1.02
Integration of growth factor signals at the c-fos serum response element. Philos Trans R Soc Lond B Biol Sci (1996) 1.00
Relation of endocrine-paracrine cells to cell proliferation in normal, hyperplastic, and neoplastic human prostate. Prostate (1991) 1.00
Induction of c-fos mRNA and AP-1 DNA-binding activity by cAMP in cooperation with either the adenovirus 243- or the adenovirus 289-amino acid E1A protein. Proc Natl Acad Sci U S A (1991) 0.98
Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate. Cancer (1997) 0.96
Sp1 and Sp3 regulate expression of the neuronal nicotinic acetylcholine receptor beta4 subunit gene. J Biol Chem (1997) 0.96
Activated 3',5'-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line. J Biol Chem (2000) 0.94
Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer. Proc Natl Acad Sci U S A (1994) 0.94
Elevation of cyclic adenosine 3',5'-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells. Cancer Res (1999) 0.91
Enhanced expression of parathyroid hormone-related protein in prostate cancer as compared with benign prostatic hyperplasia. Hum Pathol (1996) 0.89
Immunophilin ligands and GDNF enhance neurite branching or elongation from developing dopamine neurons in culture. Exp Neurol (2000) 0.88
Transcriptional regulation of neuronal nicotinic acetylcholine receptor genes. Functional interactions between Sp1 and the rat beta4 subunit gene promoter. J Biol Chem (1996) 0.88
Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons. J Neurobiol (1999) 0.88
Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations. Prostate (1997) 0.86
Effects of serotonin on neurite outgrowth from thalamic neurons in vitro. Neuroscience (1999) 0.84
Nicotine stimulates secretion of both catecholamines and acetylcholinesterase from cultured adrenal chromaffin cells. J Neurosci (1983) 0.83
Modulation of neuroendocrine differentiation in prostate cancer by interleukin-1 and -2. Prostate Suppl (1998) 0.80
Class III beta-tubulin isotype (beta III) in the adrenal medulla: II. Localization in primary human pheochromocytomas. Anat Rec (1998) 0.78
Class III beta-tubulin isotype (beta III) in the adrenal medulla: I. Localization in the developing human adrenal medulla. Anat Rec (1998) 0.77
The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest (1991) 16.06
A normal sagittal spinal configuration: a desirable clinical outcome. J Manipulative Physiol Ther (1997) 4.75
c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem (1999) 3.91
Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ (1991) 3.74
Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci U S A (1999) 3.43
Monoclonal antibodies to Rous sarcoma virus pp60src react with enzymatically active cellular pp60src of avian and mammalian origin. J Virol (1984) 3.18
New do-not-resuscitate policies. A first step in cost control. Arch Intern Med (1993) 3.05
Birth of a biome: insights into the assembly and maintenance of the Australian arid zone biota. Mol Ecol (2008) 2.73
A 42-kD tyrosine kinase substrate linked to chromaffin cell secretion exhibits an associated MAP kinase activity and is highly related to a 42-kD mitogen-stimulated protein in fibroblasts. J Cell Biol (1990) 2.41
Potentiation of epidermal growth factor receptor-mediated oncogenesis by c-Src: implications for the etiology of multiple human cancers. Proc Natl Acad Sci U S A (1995) 2.29
Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol (2000) 2.14
Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer. Breast Cancer Res (2000) 2.14
c-Src regulates the simultaneous rearrangement of actin cytoskeleton, p190RhoGAP, and p120RasGAP following epidermal growth factor stimulation. J Cell Biol (1995) 2.06
Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr Opin Cell Biol (1997) 1.97
Src family kinases and HER2 interactions in human breast cancer cell growth and survival. Oncogene (2001) 1.89
Transmission of hepatitis C within Australian prisons. Med J Aust (1999) 1.89
Marginally effective medical care: ethical analysis of issues in cardiopulmonary resuscitation (CPR) J Med Ethics (1997) 1.85
A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery. Audit of an algorithm for arthroplasty of the lower limb. J Bone Joint Surg Br (2003) 1.78
Role of the proline knot motif in oleosin endoplasmic reticulum topology and oil body targeting. Plant Cell (1997) 1.76
c-Src, receptor tyrosine kinases, and human cancer. Adv Cancer Res (1999) 1.71
c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function. Oncogene (2006) 1.69
p60c-src activity detected in the chromaffin granule membrane. Biochem Biophys Res Commun (1986) 1.62
Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management. Am J Trop Med Hyg (1974) 1.61
High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice. Clin Microbiol Infect (2012) 1.60
Augmented mitogenic responsiveness to epidermal growth factor in murine fibroblasts that overexpress pp60c-src. Mol Cell Biol (1988) 1.59
pp60c-src tyrosine kinase, myristylation, and modulatory domains are required for enhanced mitogenic responsiveness to epidermal growth factor seen in cells overexpressing c-src. Mol Cell Biol (1989) 1.56
Local degradation of fibronectin at sites of expression of the transforming gene product pp60src. Nature (1985) 1.55
Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells. Mol Carcinog (1998) 1.54
Maternal and neonatal morbidity in relation to the instrument used for mid-cavity rotational operative vaginal delivery: a prospective cohort study. BJOG (2013) 1.45
Purification and properties of beta-isopropylmalate dehydrogenase. J Biol Chem (1969) 1.41
Decision-making and outcomes of prolonged ICU stays in seriously ill patients. J Am Geriatr Soc (2000) 1.41
Usefulness of color-flow Doppler in diagnosing and in differentiating supracristal ventricular septal defect from right ventricular outflow tract obstruction. Am J Cardiol (1991) 1.39
Rapid urease test for mycobacteria: preliminary observations. J Clin Microbiol (1977) 1.38
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cancer Res (1999) 1.37
5-lipoxygenase-activating protein is an arachidonate binding protein. FEBS Lett (1993) 1.35
Caleosins: Ca2+-binding proteins associated with lipid bodies. Plant Mol Biol (2000) 1.33
Phosphotyrosine (p-Tyr)-dependent and -independent mechanisms of p190 RhoGAP-p120 RasGAP interaction: Tyr 1105 of p190, a substrate for c-Src, is the sole p-Tyr mediator of complex formation. Mol Cell Biol (1998) 1.32
Isolation and partial characterization of a monoclonal antibody to the Rous sarcoma virus transforming protein pp60src. J Virol (1983) 1.31
The origin of chloroplastic acetyl coenzyme A. Arch Biochem Biophys (1981) 1.31
Techniques for controlling variability in gram staining of obligate anaerobes. J Clin Microbiol (1995) 1.31
Role of c-Src tyrosine kinase in EGF-induced mitogenesis. Front Biosci (1997) 1.28
Identification of chromaffin granule-binding proteins. Relationship of the chromobindins to calelectrin, synhibin, and the tyrosine kinase substrates p35 and p36. J Biol Chem (1987) 1.27
Composition and role of tapetal lipid bodies in the biogenesis of the pollen coat of Brassica napus. Planta (1999) 1.27
Effect of superficial heat, deep heat, and active exercise warm-up on the extensibility of the plantar flexors. Phys Ther (2001) 1.25
Intra- and extracellular lipid composition and associated gene expression patterns during pollen development in Brassica napus. Plant J (1997) 1.24
Regulation of stromal sedoheptulose 1,7-bisphosphatase activity by pH and Mg2+ concentration. J Biol Chem (1984) 1.23
Overexpression of cellular Src in fibroblasts enhances endocytic internalization of epidermal growth factor receptor. J Biol Chem (1997) 1.22
Effect of butyrolactone I on the producing fungus, Aspergillus terreus. Appl Environ Microbiol (1998) 1.21
Methanol fixation. An alternative to heat fixation of smears before staining. Diagn Microbiol Infect Dis (1984) 1.20
Delivery outcomes for nulliparous women at the extremes of maternal age - a cohort study. BJOG (2013) 1.20
Localization of conserved and nonconserved epitopes within the Rous sarcoma virus-encoded src protein. J Virol (1986) 1.19
Differential, temporal and spatial expression of genes involved in storage oil and oleosin accumulation in developing rapeseed embryos: implications for the role of oleosins and the mechanisms of oil-body formation. Plant Mol Biol (1993) 1.19
Lipid biosynthesis from [14C]bicarbonate, [2(-14)C]pyruvate and [1(-14)C]acetate during photosynthesis by isolated spinach chloroplasts. FEBS Lett (1977) 1.19
Characterization of anther-expressed genes encoding a major class of extracellular oleosin-like proteins in the pollen coat of Brassicaceae. Plant J (1996) 1.18
Signatures of vicariance, postglacial dispersal and spawning philopatry: population genetics of the walleye Sander vitreus. Mol Ecol (2009) 1.16
Secondary structures of a new class of lipid body proteins from oilseeds. J Biol Chem (1992) 1.15
Phosphorylation of p190 on Tyr1105 by c-Src is necessary but not sufficient for EGF-induced actin disassembly in C3H10T1/2 fibroblasts. J Cell Sci (2001) 1.14
Patients' perceptions of physicians' recommendations for comfort care differ by patient age and gender. J Gen Intern Med (2000) 1.14
Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway. Oncogene (2006) 1.14
Identification and characterization of a cytoskeleton-associated, epidermal growth factor sensitive pp60c-src substrate. Oncogene (1992) 1.14
Color Doppler detection of multiple ventricular septal defects. Circulation (1986) 1.13
Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort. Diabetologia (2006) 1.12
Nucleotide sequence and temporal regulation of a seed-specific Brassica napus cDNA encoding a stearoyl-acyl carrier protein (ACP) desaturase. Plant Mol Biol (1992) 1.12
Partial purification of a mitogen-activated protein kinase kinase activator from bovine brain. Identification as B-Raf or a B-Raf-associated activity. J Biol Chem (1994) 1.12
Increased levels of p21ras-GTP and enhanced DNA synthesis accompany elevated tyrosyl phosphorylation of GAP-associated proteins, p190 and p62, in c-src overexpressors. Oncogene (1993) 1.12
Immune response to the src gene product in mice bearing tumors induced by injection of avian sarcoma virus-transformed mouse cells. J Virol (1979) 1.11
Functional association of a monoacylglycerophosphocholine acyltransferase and the oleoylglycerophosphocholine desaturase in microsomes from developing leaves. Eur J Biochem (1984) 1.11
Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells. Oncogene (1988) 1.10
Tyrosine phosphorylation of G protein alpha subunits by pp60c-src. Proc Natl Acad Sci U S A (1992) 1.10
Spin-label ESR studies of lipid-protein interactions in thylakoid membranes. Biochemistry (1989) 1.10
Characterization of graf, the GTPase-activating protein for rho associated with focal adhesion kinase. Phosphorylation and possible regulation by mitogen-activated protein kinase. J Biol Chem (1998) 1.08
Radiometric detection of carbohydrate catabolism by pathogenic Neisseria. J Clin Microbiol (1977) 1.07
The sites of phosphorylation by protein kinase C and an intact SH2 domain are required for the enhanced response to beta-adrenergic agonists in cells overexpressing c-src. Mol Cell Biol (1993) 1.06
Response of the patent ductus arteriosus to indomethacin treatment. Am J Dis Child (1987) 1.05
5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur J Biochem (1993) 1.05
A protein that is highly related to GTPase-activating protein-associated p62 complexes with phospholipase C gamma. Mol Cell Biol (1994) 1.05
Quantitative morphology of the aortic arch in neonatal coarctation. J Am Coll Cardiol (1986) 1.03
Surgery without catheterization for congenital heart defects: management of 100 patients. J Am Coll Cardiol (1987) 1.03
Effect of a substituted pyridazinone, compound BASF 13-338 on membrane lipid synthesis in photosynthetic tissues [proceedings]. Biochem Soc Trans (1980) 1.03
Functional interactions between Choline kinase α, epidermal growth factor receptor and c-Src in breast cancer cell proliferation. Oncogene (2011) 1.02
Task force 4: organization of delivery systems for adults with congenital heart disease. J Am Coll Cardiol (2001) 1.02
Hypoplastic left heart syndrome. Radiographics (2001) 1.01
Overexpression of c-src enhances beta-adrenergic-induced cAMP accumulation. Proc Natl Acad Sci U S A (1990) 1.01
A biomechanical study of distal radial fractures. J Hand Surg Am (1987) 1.01
Quantitation of cell-associated borrelial DNA in the blood of Lyme disease patients with erythema migrans. Eur J Clin Microbiol Infect Dis (2011) 1.00
A methodology for the collection of supplemental information on agricultural fatalities. Am J Ind Med (1990) 1.00
Membrane transfer of alpha-tocopherol. Influence of soluble alpha-tocopherol-binding factors from the liver, lung, heart, and brain of the rat. J Biol Chem (1981) 0.99
Biosynthesis of triacylglycerols containing very long chain monounsaturated acyl moieties in developing seeds. Plant Physiol (1990) 0.99
Development and testing of an assessment instrument for the formative peer review of significant event analyses. Qual Saf Health Care (2007) 0.98
Group A streptococcal meningitis. Pediatrics (1983) 0.98
Solubilization, purification and kinetic properties of three membrane-bound long-chain acyl-coenzyme-A thioesterases from microsomes of photosynthetic tissue. Eur J Biochem (1984) 0.97
Characterization of lipases from the lipid bodies and microsomal membranes of erucic acid-free oilseed-rape (Brassica napus) cotyledons. Biochem J (1988) 0.96
Two SH2 domains of p120 Ras GTPase-activating protein bind synergistically to tyrosine phosphorylated p190 Rho GTPase-activating protein. J Biol Chem (1995) 0.96